3rd party evaluation shows the advantages of ConverLight®.
The prime competitor to ConverLight is not foremost other electrochromic glass but rather classical mechanical solutions. The Bengt Dahlgren report shows the competitive advantages ConverLight.
The consultant company Bengt Dahlgren has through simulations compared ConverLight with internal and external sun protection solutions. Aspects like function, installation, maintenance and so on has been compared. These comparisons show the big advantages of ConverLight to the other frequently used solutions.
“For us it is important that also a 3rd party can show the obvious advantages we think ConverLight have. This evaluation is increasing the credibility in the market and will help in the sales process. Add to this that ConverLight is less expensive over the life span compared to exterior sun protection it becomes obvious that ConverLight is the best solution”, says CEO Jerker Lundgren.
Read more https://www.chromogenics.com/news/
Contact:
Jerker Lundgren, CEO
Lars Ericsson, CFO and Head of Communications
Tel: +46 (0)18 430 0430
E-mail: info@chromogenics.com
Certified Adviser: G&W Fondkommission, e-mail: ca@gwkapital.se, tel.: +46 (0) 8 503 000 50
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
About ChromoGenics
ChromoGenics offers dynamic glass with controllable heat- and light transmission and static glass with world leading performance. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.
ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. www.chromogenics.com
Tags:
